Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1346 |
---|---|
Product Name | Anti-Human CSF2 Recombinant Antibody(Lenzilumab) |
Molecular Name | Lenzilumab |
Alias | Anti-CSF2 Recombinant Antibody, Research Grade Lenzilumab |
CAS Number | 1229575-09-0 |
Target | CSF2[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, IHC, Block |
Buffer | PBS, pH7.5 |
Background | Lenzilumab (INN, development code KB003) is a humanized monoclonal antibody (class IgG1 kappa) that targets colony stimulating factor 2 (CSF2)/granulocyte-macrophage colony stimulating factor (GM-CSF). |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |